跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEFLUNOMIDA PHARMATHEN 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LEFLUNOMIDA PHARMATHEN 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
LEFLUNOMIDA PHARMATHEN 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Pharmathen S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 4, 2023
Approval ID
7061317ec5503286
Company
Pharmathen S.A.
Type
Standard
Approval Details
Approval Id
7061317ec5503286
Drug Cima Aemps Name
LEFLUNOMIDA PHARMATHEN 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
88495
Holder Company Name
Pharmathen S.A.
Marketing Company Name
Pharmathen S.A.
Holder Company Detail Path
/organization/pharmathen-s-a
Marketing Company Detail Path
/organization/pharmathen-s-a
Authorization Date
2023-01-04
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
15 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Pharmathen S.A.
Company Detail Path
/organization/pharmathen-s-a
Company Information
Pharmaceutical Company Name
PHARMATHEN S.A.
Country Name
Greece
City Name
pallini,sterea ellada and evoia,country_gr
Address
6 Dervenakion
Active Ingredients
LEFLUNOMIDA
15 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 4, 2023
Approval ID
7061317ec5503286
Type
Standard
Back to CIMA-AEMPS Approvals